Latest National Cancer Institute Stories
MANHATTAN BEACH, Calif., May 15, 2013 /PRNewswire/ -- A rigorous analysis of the Pancreatic Cancer Action Network research grants program has shown that the organization's grant recipients are leveraging their awards to secure impressive subsequent funding, publishing their findings, and enhancing knowledge about the disease. The organization evaluated their research grants program by looking at grants awarded from 2003-2011. During that time, 66 grants were awarded totaling $9.15...
Findings Demonstrate Utility of Oncotype DX® to Guide Radiation Treatment Decision for DCIS Patients and Support Expanded Access and Reimbursement REDWOOD CITY, Calif. and PHILADELPHIA, May 2, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) and the ECOG-ACRIN Cancer Research Group announced today that the Journal of the National Cancer Institute (JNCI) published positive results from their clinical validation study of the Oncotype DX® DCIS Score in patients with ductal...
By the National Cancer Institute Editor's Note: The following article is part of the monthly Lifelines education and awareness print series that the National Cancer Institute provides to African American news and information outlets BETHESDA, Md., April 22, 2013 /PRNewswire-USNewswire/ -- In communities of color, the words "clinical trial" or "research study" sometimes raise concerns that are rooted in memories of infamous studies of the past, such as the Tuskegee Syphilis Study....
Competition aims to develop more efficient treatment strategies for breast cancer patients SAN FRANCISCO, April 19, 2013 /PRNewswire/ -- Heritage Provider Network (HPN), The National Cancer Institute, Sage Bionetworks and DREAM today announced the Heritage-DREAM Breast Cancer Network Inference Challenge. The prize contest uses big data to develop more effective treatments for breast cancer, and was featured at the Sage Bionetworks Commons Congress in San Francisco, California....
Georgetown Lombardi Comprehensive Cancer Center and HackensackUMC's John Theurer Cancer Center to Develop Consortium WASHINGTON and HACKENSACK, N.J., April 9, 2013 /PRNewswire-USNewswire/ -- Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center in Washington, D.C., and John Theurer Cancer Center, part of Hackensack University Medical Center in Hackensack, N.J., announce the establishment of an oncology affiliation agreement to foster robust...
LA Biomed researcher studied the effects of combined hormone therapy Dr. Rowan Chlebowski, MD, PhD, Los Angeles Biomedical Research Institute lead researcher and author of a study released March 29 by the Journal of the National Cancer Institute, issued the following statement regarding the latest findings from the Women's Health Initiative, the largest-ever study of hormonal therapy in post-menopausal women. The study Dr. Chlebowski authored reported that estrogen plus progestin use is...
Estrogen plus progestin use is linked with increased breast cancer incidence. In addition, prognosis is similar for both users and nonusers of combined hormone therapy, suggesting that mortality from breast cancer may be higher for hormone therapy users as well, according to a study published March 29 in the Journal of the National Cancer Institute. In the Women's Health Initiative (WHI) randomized trial, estrogen plus progestin was associated with an increase in both breast cancer...
St. Jude Children's Research Hospital-led study links inherited variations in a few genes to a substantially increased risk of acute lymphoblastic leukemia and helps to explain ethnic differences in the cancer's incidence MEMPHIS, Tenn., March 19, 2013 /PRNewswire-USNewswire/ -- Humans have between 20,000 and 25,000 genes that carry instructions for assembling the proteins that do the work of cells. Work led by St. Jude Children's Research Hospital found that children who inherit...
By the National Cancer Institute Editor's Note: The following article is part of the monthly Lifelines education and awareness print series that the National Cancer Institute provides to African American news and information outlets. BETHESDA, Md., March 15, 2013 /PRNewswire-USNewswire/ -- If a screening test could not only catch cancer early but also help to prevent it, could you think of any reason not to have the test? (Logo:...
Initial vaccinations for human papillomavirus (HPV) at a young age is important for maximizing quadrivalent HPV vaccine effectiveness according to a Swedish study published March 13 in the Journal of the National Cancer Institute. HPV vaccination programs have been launched around the world in hopes of preventing cervical cancer and other HPV-related cancers. While incidence of genital warts is the earliest possible disease outcome to measure the efficacy of the HPV vaccine, the results of...
